1
Michael V Doyle, Arthur D Newell, Jack H Nunberg, Thomas J White: Human IL-2 as a vaccine adjuvant. Chiron Corporation, Donald J Pochopien, Barbara G McClung, Robert P Blackburn, September 1, 1998: US05800810 (55 worldwide citation)

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine e ...


2
Michael V Doyle, Arthur D Newell, Jack H Nunberg, Thomas J White: Human IL-2 as a vaccine adjuvant. Chiron Corporation, Roberta L Robins, Alisa A Harbin, Robert P Blackburn, May 9, 2000: US06060068 (45 worldwide citation)

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine e ...


3
Michael V Doyle, Arthur D Newell, Jack H Nunberg, Thomas J White: Human IL-2 as a vaccine adjuvant. Cetus Oncology Corporation, Barbara G McClung, Thomas C Meyers, Robert P Blackburn, April 2, 1996: US05503841 (34 worldwide citation)

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine e ...


4
Michael V Doyle, Arthur D Newell, Jack H Nunberg, Thomas J White, Gary A Anderson: Human IL-2 as a vaccine adjuvant. Cetus Corporation, Philip L McGarrigle, Albert P Halluin, March 31, 1992: US05100664 (33 worldwide citation)

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine e ...


5
Michael V Doyle, Arthur D Newell, Jack H Nunberg, Thomas J White: Human IL-2 as a vaccine adjuvant. Chiron Corporation, Donald J Pochopien, Barbara G McClung, Robert P Blackburn, July 1, 1997: US05643565 (14 worldwide citation)

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine e ...


6
Arthur D Newell, Jack Hnunberg, Michael Vdoyle, Thoms J White: Composition and method for treating animals. Cetus, Emeryville, California, 94608, Usa, QUAN GYONGLIU, April 1, 1987: CN86106369

Methods and compositions for protecting an animal against stress-induced syndrome, or for enhancing the immune response of an animal to a vaccine, which employ IL-2 as an active ingredient are described.